Author: Steven Goodstein

Otonomy Expects Clinical Results From Three Trials In 2020, Sees Lower Operating Expenses In 2020

Otonomy (OTIC) on Thursday provided an update on its product pipeline and financial guidance for 2019 to 2020. The biopharmaceutical firm said it expects to have clinical trial results for three programs in 2020 including the previously announced phase 3 trial of Otividex in Meniere’s disease, phase 1/2 trial of OTO-313 in tinnitus patients in the first half of 2020 […]

Molina Healthcare Says Extension Of CVS Caremark Service Pact To Be Earnings Accretive ‘Immediately’

Molina Healthcare Inc. (MOH) said early Thursday it extended an agreement with CVS Caremark, a unit of CVS Health (CVS), to deliver pharmacy-benefits management, or PBM, services through 2021, a move that Molina said is accretive to its earnings immediately and will also lower its costs. Under the agreement, effective Jan. 1, CVS will continue to administer pharmacy benefits for […]